Related Experiment Video
Updated: Apr 26, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
23.8K
An association between MPO -463 G/A polymorphism and type 2 diabetes
A Ergen1, H Karagedik1, Z E Karaali2
1Istanbul University, The Institute of Experimental Medicine, Department of Molecular Medicine, Capa- Istanbul, Turkey.
Folia Biologica
|July 25, 2014
Summary
The myeloperoxidase (MPO) gene's -463 G/A polymorphism influences type 2 diabetes risk. The GG genotype increases risk, while the A allele offers protection and is linked to healthier metabolic profiles.
Area of Science:
- Genetics
- Biochemistry
- Endocrinology
Background:
- Myeloperoxidase (MPO) is crucial in reactive oxygen species production.
- The MPO gene -463 G/A polymorphism affects MPO activity, with GG genotypes showing higher activity.
- Oxidative stress, linked to hyperglycemia and advanced glycosylated end products (AGE), is implicated in diabetes pathogenesis and complications.
Purpose of the Study:
- To investigate the association between the MPO -463 G/A polymorphism and type 2 diabetes.
- To explore the relationship between MPO genotypes and biochemical parameters in type 2 diabetes patients.
Main Methods:
- Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) was used to genotype the MPO -463 G/A polymorphism.
- The study included 145 type 2 diabetic patients and 151 healthy controls.
Main Results:
- The AA genotype and A allele were identified as protective against type 2 diabetes.
- The GG genotype was found to be a risk factor for type 2 diabetes.
- Individuals with the A allele exhibited lower serum cholesterol, triglyceride, VLDL levels, and body mass index.
Conclusions:
- The MPO gene, particularly the -463 G/A polymorphism, plays a significant role in the pathogenesis of type 2 diabetes.
- Increased frequency of the GG genotype in patients suggests a link between higher MPO activity/oxidant capacity and diabetes development.
Related Concept Videos
01:26Type II Diabetes I: Introduction
13
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
13
01:22Diabetes Mellitus: Type 2 and Gestational
4.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
12
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
12
01:22Diabetes Mellitus: Overview and Type I Subtype
5.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
01:24Type II Diabetes II: Pathophysiology
19
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
19
01:26Type I Diabetes II: Pathophysiology
57
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
57